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Homocysteine and mortality in 
chronic kidney disease
Studies in the general population suggest an association between 
high homocysteine levels and cardiovascular disease as well as 
mortality. Th e high prevalence of hyperhomocysteinemia in 
patients with chronic kidney disease (CKD) has generated inter-
est because total homocysteine may be a risk factor for mortality 
in these patients. Th ere is a close correlation between glomerular 
fi ltration rate (GFR) and plasma levels of homocysteine. Th ere-
fore, renal failure is associated with high prevalence of hyperho-
mocysteinemia. Many studies showing an association between 
high homocysteine levels and cardiovascular disease and mortal-
ity were conducted in populations at high risk for kidney disease, 
such as the elderly and patients with diabetes, but few of them 
adequately adjusted for kidney function. In their study, Menon 
et al. analyzed the relationship between homocysteine levels and 
cardiovascular outcome in 840 patients with CKD stages 3–4. 
Serum homocysteine was measured at baseline and related with 
all-cause and cardiovascular disease mortality. Homocysteine 
was evaluated both as tertiles (<14.7, 14.7–19.5, and ≥19.6 µmol 
per liter) and as a continuous variable (per 10 µmol per liter). 
Participants had a mean age of 52 ± 12 years and a mean GFR of 
33 ± 12 ml per minute per 1.73 m2. During a median follow-up 
of 10 years, 195 (24%) died from any cause, and 118 (15%) died 
from cardiovascular disease. Th e level of GFR was lower and 
proteinuria higher in the highest homocysteine tertile. Th ere was 
no association between the highest tertile of homocysteine and 
all-cause mortality; this relationship was further attenuated by 
adjustment for GFR. Th ere was no association between homo-
cysteine as a continuous variable and all-cause or cardiovascular 
mortality. Hence, hyperhomocysteinemia does not appear to be 
a risk factor for all-cause or cardiovascular mortality in patients 
with CKD. Prior studies demonstrating an association between 
plasma homocysteine and cardiovascular risk may have inad-
equately adjusted for the confounding eff ects of kidney function. 
(Circulation 2006; 113: 1572–1577)
Juan Oliver
The vascular wall contains resident 
progenitor cells
Angiogenesis is defi ned as outgrowth of new vessels from pre-
existing blood vessels. Th e main steps in this process include 
endothelial-cell migration, proliferation, and tube formation. A 
large body of work has suggested a role for circulating endothelial 
precursor cells (C-EPCs) and/or bone marrow-derived endothe-
lial precursor cells (BM-EPCs) in new blood vessel formation, a 
process defi ned as postnatal vasculogenesis. Although homing 
of C-EPCs at sites of new vessel formation has been shown, the 
exact role of BM-EPCs has been unclear. Recent data demon-
strate that BM-EPCs are recruited to the vessel wall rather than 
to endothelium, and that these cells can be a source of vascular 
cells and macrophages.1,2 In a new study, Zengin et al. report the 
existence of EPCs and stem cells in a distinct zone of the vascular 
wall that are capable of diff erentiating into mature endothelial 
cells, hematopoietic cells, and local immune cells, such as macro-
phages.3 Th ey identifi ed this zone to be localized between smooth 
muscle and the adventitial layer of the human adult vascular wall. 
It predominantly contains cells that are CD34+ but CD31–, which 
also express VEGFR2 and TIE2. Only a few cells in this zone of 
the vascular wall are positive for CD45. In a ring assay using frag-
ments of human internal thoracic artery, the authors showed that 
the CD34+ cells of the vessel wall form capillary sprouts ex vivo 
and are apparently recruited for capillary formation by tumor 
cells. New vessels formed by these vascular wall resident EPCs 
express markers for angiogenically activated endothelial cells, 
such as CEACAM1, and also for mature endothelial cells, such 
as VE-cadherin or occludin. Vascular wall areas containing EPCs 
were found in large- and middle-sized arteries and veins of all 
organs studied. Th ese surprising results suggest the existence of a 
‘stem-cell zone’ in the wall of adult human blood vessels, probably 
important in the maintenance of normal vascular homeostasis 
(see fi gure). EC, endothelial cell; SMC, smooth muscle cell; ADV, 
adventitia.  (1Blood 2004; 104: 2084–2086. 2Circ Res 2004; 95: 
E56–E64. 3Development 2006; 133: 1543–1551) 
Juan Oliver
Angiotensin and glomerular 
permeability
Inhibitors of angiotensin II action have emerged as the most 
eff ective drugs to preserve glomerular function in renal diseases. 
It has long been known that angiotensin II induces proteinuria, 
and that angiotensin-converting enzyme inhibitors preserve the 
size-selective restriction to macromolecules of the glomerular 
capillaries. Recent work suggests that angiotensin II induced 
podocyte dysfunction in a rat model of glomerulosclerosis. Now, 
Macconi et al. present data showing that, in rat podocytes, angio-
tensin II induced reorganization of F-actin fi bers and redistribu-
tion of zonula occludens-1 (ZO-1) that is physically associated 
with actin. Th ese eff ects were paralleled by increased albumin 
permeability across podocyte monolayers. Th e F-actin stabilizer 
jasplakinolide prevented both ZO-1 redistribution and albumin 
leakage, suggesting that actin cytoskeleton rearrangement is 
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instrumental to podocyte permselective dysfunction induced 
by angiotensin II. Changes in both F-actin and ZO-1 patterns 
were confi rmed in glomeruli of rat-isolated perfused kidneys 
on short infusion of angiotensin II, leading to increased protein 
excretion. Podocyte dysfunction was mediated by angiotensin II 
receptor 1 and was partly dependent on Src kinase–phospholi-
pase C activation. Th ese data demonstrate that strategies aimed 
at stabilizing podocyte–podocyte contacts and targeting the rele-
vant intracellular signal transduction pathways are new avenues 
of research to design renoprotective therapies. (Am J Pathol 2006; 
168: 1073–1085) 
Juan Oliver
Interaction of T cells with dendritic 
cells
New research has revealed the dynamics of live T-cell inter-
actions in the lymph nodes of live mice, using laser-scanning 
micro scopy. T-cell interactions with antigen-presenting dendritic 
cells in lymph nodes are diff erent from those observed in vitro 
and suggest that an intact lymphoid organ structure is needed 
to develop normal immune responses. Th ey also indicate that in 
the absence of immunization, T cells move extensively within 
the T-cell zones of lymph nodes, facilitating the rare interaction 
between antigen-specifi c T cells and antigen-loaded dendritic 
cells. Upon encounter with an antigen, T cells partake in dynamic 
interactions of varying lengths, then stop their movement for sev-
eral hours before regaining motility by 36 hours. And, although 
we know that regulatory T (T reg) cells exert powerful down-
modulatory eff ects on immune responses, it is not known how 
they act in vivo. In their study, Tadokoro et al. used intravital 
two-photon laser-scanning microscopy to visualize the behavior 
of autoantigen-specifi c T cells in the presence or absence of natu-
rally occurring T reg cells in intact lymph nodes. In the absence 
of T reg cells, the movement of autoantigen-specifi c T cells inside 
lymph nodes decreased, and the contacts between T cells and 
antigen-loaded dendritic cells increased. Th e authors conclude 
that T reg cells can have an early eff ect on immune responses. 
(J Exp Med 2006; 203: 505–511) 
Detlef Schlöndorﬀ 
The role of lymphatic endothelial 
progenitor cells in de novo 
lymphangiogenesis in human 
renal transplants
De novo lymphangiogenesis infl uences the course of diff erent 
human diseases, from chronic renal transplant rejection to tumor 
metastasis. Th e cellular mechanisms of lymphangiogenesis in 
human diseases are unknown and may involve division of local 
preexisting endothelial cells or incorporation of circulating pro-
genitors. Recently, Kerjaschki et al. analyzed renal tissues of indi-
viduals with gender-mismatched transplants who had transplant 
rejection and high rates of overall lymphatic endothelial prolifera-
tion as well as massive chronic infl ammation. Donor-derived cells 
were detected by in situ hybridization of the Y chromosome. Th e 
authors compared these tissues with biopsies of essentially normal 
skin and intestine, and two rare carcinomas with low rates of lym-
phatic endothelial proliferation that were derived from individuals 
with gender-mismatched bone marrow transplants. Th ey found 
the participation of recipient-derived lymphatic progenitor cells in 
renal transplants. In contrast, lymphatic vessels of normal tissues 
and those around post-transplant carcinomas did not incorporate 
donor-derived progenitors. Th is indicates a stepwise mechanism 
of infl ammation-associated de novo lymphangiogenesis, implying 
that potential lymphatic progenitor cells derive from the circu-
lation, transmigrate through the connective tissue stroma, pre-
sumably in the form of macrophages, and incorporate into the 
growing lymphatic vessel. (Nat Med 2006; 12: 230–234)
Detlef Schlöndorﬀ 
Reprinted from Am J Pathol 2006;168: 1073–1085, with 
permission from the American Society for Investigative Pathology
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